CDLQI Scores range from 0 to 30. Lower scores indicate better health‐related quality of life. Calculations are based on the change from baseline to week 12 in both groups · people with paediatric psoriasis
1 finding from 1 review
Total active flexion at three months Major outcome group 5 (adverse effects) Total active flexion (TAF) of MCPJ, PIPJ and DIPJ; lower value indicates loss of flexion and a worse outcome · 210 participants with Dupuytren's disease of the fingers in 2 studies (225 digits reported across all studies) (Collis 2013;…
1 finding from 1 review
Intervention not reported
Pain (at study completion) WOMAC (VAS or NRS) from 0 to 20; lower scores mean reduced pain · People with hip or knee osteoarthritis
1 finding from 1 review
Intervention not reported
Physical function (at study completion) WOMAC (self administered health status measure) from 0 to 68; lower scores mean better function · People with hip or knee osteoarthritis
1 finding from 1 review
Depression (lower scores mean less depression) · participants with improving parental and infant mental health
1 finding from 1 review
Depression (lower scores mean less depression) · participants with improving parental and infant mental health
1 finding from 1 review
Intervention not reported
Fatigue (lower scores mean less fatigue) · Patients with fibromyalgia
1 finding from 1 review
Intervention not reported
Sleep problems (lower scores mean less sleep problems) · Patients with fibromyalgia
1 finding from 1 review
Intervention not reported
Depression (lower scores mean less depression) · Patients with fibromyalgia
1 finding from 1 review
Parent‐child relationship or assessment of parenting · children with overweight or obesity
1 finding from 1 review
Performance measures: lower extremity strength · Older or community-dwelling adults
Meta-analysis of randomised trials of vitamin D supplementation for Performance measures: lower extremity strength, Older adults: SMD 0.05 (95% CI -0.11 to 0.20), not statistically significant. Umbrella review outcome-level evidence grade: Substantial effect unlikely.
1 finding from 1 review
SMD 0.05 [-0.11, 0.20]
3 studies
GRADE not reported
Duration of grade IV neutropenia (lower values signify better outcomes) · people with chemotherapy‐induced febrile neutropenia
Benefits and harms of CSF plus antibiotics showed no clear difference in duration of grade IV neutropenia (lower values signify better… compared with antibiotics alone (low certainty).
1 finding from 1 review
Time to recovery from fever (lower values signify better outcomes) · people with chemotherapy‐induced febrile neutropenia
Benefits and harms of CSF plus antibiotics showed no clear difference in time to recovery from fever (lower values signify better outcomes) compared with antibiotics alone (low certainty).
1 finding from 1 review
Time to withdrawal from ATB (lower values signify better outcomes) · people with chemotherapy‐induced febrile neutropenia
Benefits and harms of CSF plus antibiotics showed no clear difference in time to withdrawal from ATB (lower values signify better outcomes) compared with antibiotics alone (low certainty).
1 finding from 1 review
Pain intensity (0‐10cm visual analogue scale) · hip replacement
1 finding from 1 review
Physical function · hip replacement
1 finding from 1 review
Postoperative anxiety · hip replacement
1 finding from 1 review
Pain WOMAC pain. Scale from: 0 to 100 (lower scores indicate less pain). · patients with knee replacement surgery
1 finding from 1 review
Functional ability · patients with knee replacement surgery
1 finding from 1 review
Pain Visual analog scale Scale from 0 to 100 (lower is better) · patients with extensor carpi radialis tendinitis
1 finding from 1 review